You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TTR-mediated amyloidosis

Showing 1 - 25 of 3,264
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study of Transthyretin-Mediated Amyloidosis

Recruiting
  • Transthyretin-Mediated Amyloidosis
  • ATTR Amyloidosis
    • La Jolla, California
    • +23 more
    Jan 13, 2023

    Transthyretin-mediated Amyloidosis With Cardiomyopathy, ATTR Amyloidosis With Cardiomyopathy Trial (Patisiran)

    Available
    • Transthyretin-mediated Amyloidosis With Cardiomyopathy
    • ATTR Amyloidosis With Cardiomyopathy
    • (no location specified)
    Aug 17, 2022

    Patients With hATTR With Polyneuropathy Treated With Patisiran

    Not yet recruiting
    • Transthyretin Amyloidosis
    • Amyloidosis, Hereditary
    • Six minutes walk test
    • Bordeaux, France
    • +7 more
    May 24, 2023

    Amyloidosis Trial in Worldwide (Patisiran (ALN-TTR02))

    Completed
    • Amyloidosis
    • Patisiran (ALN-TTR02)
    • La Mesa, California
    • +55 more
    Jan 19, 2023

    Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Trial in Indianapolis, Boston (Eplontersen)

    Recruiting
    • Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
    • Indianapolis, Indiana
    • +19 more
    Jan 31, 2023

    Amyloidosis, Familial, Transthyretin Amyloidosis Trial in Worldwide (Patisiran)

    Completed
    Has Results
    • Amyloidosis, Familial
    • Transthyretin Amyloidosis
    • Créteil, France
    • +8 more
    Nov 22, 2021

    Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)

    Recruiting
    • Polyneuropathy
    • Amyloidosis
    • ECG + echocardiography
    • Answering questionnaires
    • Jette, Belgium Capital City, Belgium
      UZ Brussel
    Jul 14, 2023

    Patisiran in Polyneuropathy of ATTRv Amyloidosis WithV122I or

    Active, not recruiting
    • Hereditary Transthyretin-mediated (ATTRv) Amyloidosis
    • Polyneuropathy
    • Los Angeles, California
    • +26 more
    Mar 4, 2022

    TTR-mediated Amyloidosis Trial in Canada, United Kingdom, United States (Revusiran (ALN-TTRSC))

    Completed
    Has Results
    • TTR-mediated Amyloidosis
    • Revusiran (ALN-TTRSC)
    • Boston, Massachusetts
    • +4 more
    Jul 7, 2020

    Hereditary Transthyretin Amyloidosis in Pre-symptomatic Mutation

    Recruiting
    • Amyloidosis
      • Roma, Italy
        Flavia Torlizzi
      Feb 22, 2023

      Transthyretin Cardiac Amyloidosis Trial in Dallas (Tafamidis 61 MG)

      Not yet recruiting
      • Transthyretin Cardiac Amyloidosis
      • Tafamidis 61 MG
      • Dallas, Texas
        UT Southwestern Medical Center
      Aug 2, 2022

      Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR

      Not yet recruiting
      • Amyloidosis, Hereditary
      • +4 more
        • New York, New York
        • +2 more
        Aug 3, 2022

        Amyloid Cardiomyopathy Trial in Angers, Orléans, Tours (SPECT MPI)

        Recruiting
        • Amyloid Cardiomyopathy
        • SPECT MPI
        • Angers, France
        • +2 more
        Jun 22, 2022

        Wild-type Amyloid Cardiopathy Trial in Bordeaux, Nantes, Toulouse (electromyogram)

        Recruiting
        • Wild-type Amyloid Cardiopathy
        • electromyogram
        • Bordeaux, France
        • +2 more
        Jul 4, 2022

        Transthyretin Amyloidosis Trial in New Haven (Computer algorithm for ATTR)

        Not yet recruiting
        • Transthyretin Amyloidosis
        • Computer algorithm for ATTR
        • New Haven, Connecticut
          Yale New Haven Hospital
        Jan 20, 2023

        Transthyretin Amyloid Cardiomyopathy (ATTR CM) Trial in Baltimore (NNC6019-0001, Placebo (NNC6019-0001))

        Recruiting
        • Transthyretin Amyloid Cardiomyopathy (ATTR CM)
        • Baltimore, Maryland
          Novo Nordisk Investigational Site
        Aug 9, 2022

        Vyndaqel Capsules Special Investigation (ATTR-CM)

        Recruiting
        • Transthyretin (TTR) Amyloid Cardiomyopathy
        • Treatment for TTR amyloidosis
        • Tokyo, Japan
          Pfizer
        Jun 15, 2022

        Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Trial in Indianapolis (Eplontersen)

        Recruiting
        • Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
        • Indianapolis, Indiana
          Indiana University Health University Hospital
        Jan 12, 2023

        Healthy Volunteers, hATTR Amyloidosis Trial in Toronto (AKCEA-TTR-LRx, Placebo)

        Completed
        • Healthy Volunteers
        • hATTR Amyloidosis
        • Toronto, Ontario, Canada
          Bio Pharma Services, Inc.
        Mar 12, 2020

        Transthyretin-Mediated Amyloidosis Trial in London (ALN-TTRSC04, Placebo)

        Not yet recruiting
        • Transthyretin-Mediated Amyloidosis
        • London, United Kingdom
          Clinical Trial Site
        Dec 15, 2022

        Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Trial (NTLA-2001, Placebo)

        Not yet recruiting
        • Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
        • NTLA-2001
        • Placebo
        • (no location specified)
        Nov 8, 2023

        Patisiran-Lipid Nanoparticle Pregnancy Surveillance Program

        Recruiting
        • Hereditary Transthyretin-mediated (hATTR) Amyloidosis
        • Polyneuropathy
          • Iowa City, Iowa
          • +6 more
          Aug 11, 2022

          Transthyretin Amyloid Cardiopathy Trial in Boston (ION 682884)

          Not yet recruiting
          • Transthyretin Amyloid Cardiopathy
          • ION 682884
          • Boston, Massachusetts
            Brigham and Women's Hospital
          Apr 12, 2021

          Lumbar Spine Stenosis Specimens for Identification of

          Not yet recruiting
          • Lumbar Spinal Stenosis
          • +5 more
          • Tc99-PYP or Tc99-HDMP Scan
          • Beverly Hills, California
          • +5 more
          Sep 12, 2023

          Cancer, Cardiovascular Diseases, Hereditary Cancer Trial in Philadelphia (e-Health (web-based) disclosure portal, Provider

          Enrolling by invitation
          • Cancer
          • +3 more
          • e-Health (web-based) disclosure portal
          • Provider mediated disclosure
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Jan 31, 2023